SCHEMBL29524945

SCHEMBL29524945

CCOC(=O)c1ccc(C)nn1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.56
TSHR P16473 1/20 0.47
MAPT P10636 3/20 0.45
ALDH1A1 P00352 5/20 0.44
LMNA P02545 2/20 0.44
CA12 O43570 3/20 0.44
CA1 P00915 3/20 0.44
CA2 P00918 3/20 0.44
CA7 P43166 3/20 0.44
CA9 Q16790 3/20 0.44
CA14 Q9ULX7 3/20 0.44
ESR1 P03372 1/20 0.44
ESR2 Q92731 1/20 0.44
MEN1 O00255 1/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
KMT2A Q03164 1/20 0.44
CYP3A4 P08684 1/20 0.43
MAOA P21397 1/20 0.43
GAA P10253 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13197220 1.00 CYP1A2 (0.56) CYP1A2TSHRMAPTALDH1A1LMNA
SCHEMBL5642066 0.92 CYP1A2 (0.64) CYP1A2TSHRMAPTALDH1A1LMNA
SCHEMBL1645260 0.85 CYP1A2 (0.56) CYP1A2TSHRMAPTALDH1A1LMNA
SCHEMBL5169193 0.83 CYP1A2 (0.55) CYP1A2TSHRMAPTALDH1A1LMNA
SCHEMBL24880489 0.81 CYP1A2 (0.53) CYP1A2TSHRMAPTALDH1A1LMNA
SCHEMBL2473041 0.81 CYP1A2 (0.53) CYP1A2TSHRMAPTALDH1A1LMNA
SCHEMBL12228821 0.81 CYP1A2 (0.53) CYP1A2TSHRMAPTALDH1A1LMNA
SCHEMBL1646668 0.80 CYP1A2 (0.51) CYP1A2TSHRMAPTALDH1A1LMNA
SCHEMBL11886132 0.80 MAPK1 (0.48) CYP1A2TSHRMAPTALDH1A1CA12
SCHEMBL31226268 0.80 MAPK1 (0.48) CYP1A2TSHRMAPTALDH1A1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3982958-A1 SUBSTITUTED HETEROAROMATIC PYRAZOLO-PYRIDINES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS Janssen Pharmaceutica NV (BE) 2022-04-20 EP disclosed